TITLE

FDA Actions

PUB. DATE
October 2009
SOURCE
Internal Medicine Alert;10/16/2009 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the actions made by the U.S. Food & Drug Administration (FDA) with regards to the administration and marketing of several drugs including tumor necrosis factor (TNF)-blockers, dipeptidyl peptidase-4 (DPP-4) and orlistat.
ACCESSION #
44960616

 

Related Articles

  • Reprocessed Device Regulation. Fenske, Sean // Surgical Products;Aug2001, Vol. 20 Issue 10, p6 

    Comments on the enforcement of regulations on reprocessing of single-use devices by the Food and Drug Administration in the United States. Issuance of mandatory recall for health risk by hospitals violating the regulations; Impact of regulation enforcement on patients.

  • From the land of pop. Koberstein, Wayne // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p14 

    Opposes the US Food and Drug Administration's approval on direct-to-consumer (DTC) advertising of pharmaceutical products. Huge spending of pharmaceutical companies in consumer advertising; Presence of risks in DTC advertising; Encouragement of patients to seek specific treatments.

  • Who's Minding Health Claims on Food?  // Tufts University Health & Nutrition Letter;Jul99, Vol. 17 Issue 5, p1 

    Discusses the issue of structure/function claims and health claims in food packages in the United States. Differences between structure/function claims and health claims; Restriction of health claims by the Food and Drug administration; Examples of structure/function claims.

  • Supplement Industry Can Now Make More Unapproved Claims.  // Tufts University Health & Nutrition Letter;Feb2000, Vol. 17 Issue 12, p6 

    Focuses on the proposed rule by the United States Food and Drug Administration that would let the supplement industry make claims that have not been reviewed and approved by any agency. Definition of a disease as proposed by the agency; Amendment on the agency's proposed rule; Component of the...

  • Label Lingo.  // Current Health 2;Oct2000, Vol. 27 Issue 2, p15 

    Presents a quiz on matching legal definitions of various types of bottled water, based on rules of the United States Food and Drug Administration.

  • Untitled.  // DCI;Nov93, Vol. 153 Issue 5, p10 

    Reports on the possible reclassification of aluminum and aluminum-zirconium salts from Category 1 to Category III status in the Over-the-Counter Monograph issued by the Food and Drug Administration. Impact on the antiperspirant business; Data on the health hazards of active ingredients in...

  • Washington letter.  // DCI;Apr94, Vol. 154 Issue 4, p10 

    Reports on the move of the Food and Drug Administration (FDA) to use a novel regulatory approach for some key cosmetic ingredients. Limit on hormones pregnenolone acetate and progesterone; Regulation of alpha hydroxy acids; Drugs pending approval by the FDA.

  • Washington letter.  // DCI;Apr94, Vol. 154 Issue 4, p10 

    Reports on the permission granted by the Food and Drug Administration (FDA) to use FD&C Blue No.1 and FD&C Red no.40.

  • Washington letter.  // DCI;Jun94, Vol. 154 Issue 6, p10 

    Reports on the US Food and Drug Administration's (FDA) concern about products containing alpha-hydroxy acids (AHA) as to their claims and safety. Dangers of long-term effects of AHAs; Media coverage of the FDA's stand on AHAs.

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics